Literature DB >> 8513399

Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects.

E R Skinner1, C Watt, J A Besson, P V Best.   

Abstract

In the present study, a comparison was made of the fatty acid composition of the grey and white matter of the frontal, parietal and parahippocampal regions of post-mortem brains of patients who had died with Alzheimer's disease (n = 15) and control postmortem subjects (n = 10). Diagnosis of Alzheimer-type disease was based on the presence of senile plaques and neurofibrillary tangles in post-mortem sections. Several highly significant and specific differences were observed between the two groups. Adrenic acid (22:4 n-6) was three to four times higher in the grey matter but lower in the white matter in each of the three regions in the Alzheimer brains than in the control group. These alterations were compensated by reciprocal changes in 18:0 in the grey matter and 16:1 fatty acids in the white matter. There was no significant difference in the proportion of other fatty acids, including those of the n-6 and n-3 series, in either the grey or the white matter of any of the three regions of the two groups, except for a higher proportion of 22:6 n-3 in the parietal white matter in the Alzheimer patients. There was no significant relationship between the levels of the individual fatty acids and age at death. It is suggested that the alterations in the fatty acid composition observed in the brains of Alzheimer patients may be caused by an aberration in the system by which essential fatty acids are transported into the brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513399     DOI: 10.1093/brain/116.3.717

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  26 in total

1.  Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping.

Authors:  W A Daniel; J Wójcikowski; A Pałucha
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding.

Authors:  Sarah K Orr; Jasmin Y M Tong; Jing X Kang; David W L Ma; Richard P Bazinet
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

3.  Decreases in Phospholipids Containing Adrenic and Arachidonic Acids Occur in the Human Hippocampus over the Adult Lifespan.

Authors:  Sarah E Hancock; Michael G Friedrich; Todd W Mitchell; Roger J W Truscott; Paul L Else
Journal:  Lipids       Date:  2015-05-23       Impact factor: 1.880

4.  Cats, "rats," and bats: the comparative biology of aging in the 21st century.

Authors:  Steven N Austad
Journal:  Integr Comp Biol       Date:  2010-09-16       Impact factor: 3.326

5.  The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging.

Authors:  Sarah E Hancock; Michael G Friedrich; Todd W Mitchell; Roger J W Truscott; Paul L Else
Journal:  Geroscience       Date:  2017-01-22       Impact factor: 7.713

6.  A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

Authors:  Giselle P Lim; Frédéric Calon; Takashi Morihara; Fusheng Yang; Bruce Teter; Oliver Ubeda; Norman Salem; Sally A Frautschy; Greg M Cole
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

7.  Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.

Authors:  Thomas Fraser; Hannah Tayler; Seth Love
Journal:  Neurochem Res       Date:  2009-11-11       Impact factor: 3.996

8.  Fatty acid composition in postmortem brains of people who completed suicide.

Authors:  Aleksandra Lalovic; Emile Levy; Lilian Canetti; Adolfo Sequeira; Alain Montoudis; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

9.  Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis.

Authors:  Mingqin Zhu; Xiuzhe Wang; Erik Hjorth; Romain A Colas; Lisa Schroeder; Ann-Charlotte Granholm; Charles N Serhan; Marianne Schultzberg
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

10.  Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.

Authors:  Giuseppe Astarita; Kwang-Mook Jung; Nicole C Berchtold; Vinh Q Nguyen; Daniel L Gillen; Elizabeth Head; Carl W Cotman; Daniele Piomelli
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.